2m 2m 2m 2m 2m 2m 2m
HARVARD BIO (HBIO)
NASDAQ
$5.93-$0.13 (-2.13%)
Price as of Jun 23, 2026 6:28 PM EDT- $27.3MMarket Cap
- 17.87%1-Year Change
- Medical Instruments & SuppliesIndustry
HARVARD BIO (HBIO)
$5.93-$0.13 (-2.13%)
HBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.05 | ||
Change | +$0.19 (+3.15%) | ||
Open | $5.92 | ||
High | $6.17 | ||
Low | $5.87 | ||
Previous Close | $5.87 | ||
Volume | 17,957 | ||
30-Day Average Volume | 25,814 | ||
1-Week Change | 1.09% | ||
1-Month Change | 8.32% | ||
1-Year Change | 17.87% | ||
3-Year Change | -90.02% | ||
5-Year Change | -91.63% | ||
Fundamentals | |||
Shares Outstanding | 4.5M | ||
Total Assets | $77.9M | ||
Market Cap | $27.3M | ||
Enterprise Value | $56.4M | ||
Period: QTR TTM FY | |||
Revenue | $20.8M | ||
Net Income | -$3.4M | ||
Free Cash Flow | -$1.1M | ||
EBIT | -$1.6M | ||
EBITDA | -$1.1M | ||
Net Working Capital | $23.6M | ||
EPS | -$0.77 | ||
Enterprise Value/EBITDA | -50 | ||
Enterprise Value/Revenue | 3 | ||
P/B | 3 | ||
P/E | -8 | ||
PEG | 0 | ||
Price/Free Cash Flow | -25 | ||
Price/Operating Cash Flow | -41 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 03/16/2026 | ||
Earnings & Revenue